RESUMO

Recombinant adenoviral vectors have emerged as an attractive system for veterinary vaccines development. However, for poultry vaccination a very important criterion for an ideal vaccine is its low cost. The objective of this study was to test the ability of chicken CD154 to enhance the immunogenicity of an adenoviral vector-based vaccine against avian influenza virus in order to reduce the amount of antigen required to induce an effective immune response in avian. Chickens were vaccinated with three different doses of adenoviral vectors encoding either HA (AdHA), or HA fused to extracellular domain chicken's CD154 (AdHACD). Hemagglutination inhibition (HI) assay and relative quantification of IFN-γ showed that the adenoviral vector encoding for the chimeric antigen is able to elicit an improved humoral and cellular immune response, which demonstrated that CD154 can be used as a molecular adjuvant allowing to reduce in about 50-fold the amount of adenoviral vector vaccine required to induce an effective immune response.

Assuntos

Ligante de CD40/imunologia , Imunidade Celular/imunologia , Imunidade Humoral/imunologia , Proteínas Recombinantes de Fusão/imunologia , Vacinas Virais/imunologia , Adenoviridae/genética , Animais , Anticorpos Antivirais/sangue , Ligante de CD40/genética , Linhagem Celular , Galinhas , Ordem dos Genes , Vetores Genéticos/genética , Interferon gama/imunologia , Leucócitos Mononucleares/imunologia , Camundongos , Proteínas Recombinantes de Fusão/genética , Vacinas Virais/genética